Results 221 to 230 of about 162,220 (306)

Domiciliary oxygen for interstitial lung disease

, 2001
Alan Crockett, Josephine M Cranston, Nic Antic   +2 more
openalex   +2 more sources

Pulmonary congestion relief by adding dapagliflozin to intravenous loop diuretic in acute heart failure patients

ESC Heart Failure, EarlyView.
Abstract Aims We aim to assess the efficacy of congestion relief and safety associated with adding SGLT2i (viz., dapagliflozin 10 mg) to intravenous loop diuretics within 24 h of hospital presentation in patients with acute heart failure (AHF). Methods and results A single‐centre open‐label clinical research study enrolled 98 patients admitted with an ...
Daniela Mocan, Maria Puschita, Diana Lungeanu, Adina Pop‐Moldovan, Luminita Pilat, Dan Darabantiu, Radu Jipa, Radu Ioan Lala   +7 more
wiley   +1 more source

Progression of interstitial lung disease after the Envisia Genomic Classifier. [PDF]

ERJ Open Res
Chung A, Oh A, Durant C, Watson R, Channick J, Fishbein G, Pourzand L, Kim S, Ronaghi R, Oh S, Kim G, Weigt SS.   +11 more
europepmc   +1 more source

Diffuse Infiltrative Lung Disease -New Clinical Biomaker in Diffuse Interstitial Pneumonia.

, 2001
Shosaku Abe, Hiroki Takahashi
openalex   +2 more sources

Longitudinal changes in KL6 levels predict acute exacerbation in fibrotic interstitial lung disease. [PDF]

Sci Rep
Shiroshita A, Anan K, Shirakawa C, Shiba H, Yajima N.   +4 more
europepmc   +1 more source

Two‐year outcomes of a cardiac microcurrent device in chronic heart failure: A first‐in‐human pilot study

ESC Heart Failure, EarlyView.
Abstract Aims In heart failure patients, altered myocardial electrical fields linked to oedema may impair left ventricular function. While short‐term use of implanted microcurrent generators (C‐MIC) has shown promise, long‐term effects remain unclear.
Dragana B. Kosevic, Una Radak, Petar Vukovic, Jan D. Schmitto, Kersten Brandes, Peter Goettel, Hans‐Dirk Duengen, Elvis Tahirovic, Marija Zdravkovic, Johannes Mueller, Faouzi Kallel, Marat Fudim, Stefan D. Anker, Jesus Eduardo Rame, Miodrag Peric   +14 more
wiley   +1 more source

Homocysteine and risk of interstitial lung disease: A mendelian randomization approach to causal inference. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Li S, Hu X, Hu X, Liu H, Meng S.
europepmc   +1 more source

Intractable complication of collagen disease. Advances in diagnosis and treatment. I. Pathological change of lung. 2. Interstitial pneumonia.

, 2001
山田 秀裕, 山前 正臣, 山崎 宜興, 加勢 千容, 浜 信昭   +4 more
openalex   +2 more sources

Microvascular obstruction in cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Abstract Aims Cardiac amyloidosis (CA) is characterized by deposition of amyloid fibrils within the extracellular space, causing disarray of the myocardial structure and capillary architecture. This study aims to characterize the prevalence of microvascular obstruction (MVO) in patients with CA and to assess the association between MVO and prognosis ...
Lucrezia Netti, Adam Ioannou, Ana Martinez‐Naharro, Yousuf Razvi, Aldostefano Porcari, Lucia Venneri, Viviana Maestrini, Dan Knight, Ruta Virsinskaite, Muhammad U. Rauf, Tushar Kotecha, Rishi K. Patel, Ashutosh Wechelakar, Helen Lachmann, Peter Kellman, Charlotte Manisty, James Moon, Philip N. Hawkins, Julian D. Gillmore, Marianna Fontana   +19 more
wiley   +1 more source

Drug-induced interstitial lung disease: a pharmacovigilance study of twelve immunomodulatory and antineoplastic agents. [PDF]

J Pharm Health Care Sci
Yayan J, Rasche K.
europepmc   +1 more source